Aura Biosciences (AURA) Total Non-Current Liabilities (2020 - 2022)

Aura Biosciences has reported Total Non-Current Liabilities for 3 years, with the latest figure at $5.9 million in Q2 2022.

• For the quarter ending Q2 2022, Total Non-Current Liabilities changed N/A year-over-year to $5.9 million; the trailing twelve-month figure through Jun 2022 stood at $5.9 million (changed N/A YoY), and the FY2021 full-year result was $7.6 million, up 185.95% from the prior year.
• Total Non-Current Liabilities for Q2 2022 stood at $5.9 million, up from $5.2 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $7.6 million in Q4 2021, with the low at $2.7 million in Q4 2020.
• Historically, Total Non-Current Liabilities has averaged $5.5 million across 3 years, with a median of $5.9 million in 2022.
• The largest YoY upside for Total Non-Current Liabilities was 185.95% in 2021 against a maximum downside of 185.95% in 2021.
• Aura Biosciences' Total Non-Current Liabilities stood at $2.7 million in 2020, then surged by 185.95% to $7.6 million in 2021, then slipped by 23.18% to $5.9 million in 2022.
• The last three Total Non-Current Liabilities figures came in at $5.9 million (Q2 2022), $5.2 million (Q1 2022), and $7.6 million (Q4 2021), per Business Quant data.